新闻 April 11, 2026 Precision diagnosis of MOG antibody-associated disease is critical for timely, targeted therapy Mayo Clinic offers the first coordinated, multidisciplinary clinic in the world that is devoted specifically to MOGAD, a rare antibody-mediated inflammatory demyelinating disorder. April 11, 2026 Early intervention can halt progression of keratoconus Growing global awareness, increasing research, improved diagnostic capabilities, and expanding treatments have made keratoconus detection possible at earlier stages, leading to therapies that can meaningfully reduce or [...] April 11, 2026 Graduating residents: Building on a solid foundation The Ophthalmology Residency at Mayo Clinic provides a strong clinical, surgical and academic foundation, preparing graduates for comprehensive practice or subspecialty training. Dec. 13, 2025 Dual focus, one goal: Neuro-ophthalmology provides comprehensive evaluation for an accurate diagnosis Mayo Clinic offers specialized care in neuro-ophthalmology, which includes treating a broad spectrum of diseases such as defects of the neuromuscular junction, cranial neuropathies or inflammation of the optic nerves. Dec. 13, 2025 Facial reanimation clinic: Complex conditions require team approach The facial reanimation clinic at Mayo Clinic in Rochester, Minnesota, brings a multidisciplinary team together to collaboratively assess and treat patients of all ages with a wide range of facial nerve disorders. Dec. 13, 2025 Novel surgical approach for retinal gene therapy shows promise A recent Mayo Clinic study explores a novel approach to retinal gene therapy using fibrin hydrogels encapsulating adeno-associated virus 2-green fluorescent protein. Aug. 21, 2025 Addressing challenging uveitis cases through collaboration and tailored therapies Recognizing that uveitis often reflects underlying systemic autoimmune or inflammatory disease, Mayo Clinic takes a multidisciplinary approach that brings together ophthalmologists, rheumatologists, immunologists and ot[...] Aug. 21, 2025 Case study: Novel surgical technique for correcting excyclotropia A new surgical approach for correcting excyclotropia has shown promising results, according to a retrospective case series conducted by Mayo Clinic researchers. April 02, 2025 Advancing patient care through glaucoma research Glaucoma is the leading cause of irreversible blindness with 80 million patients affected worldwide. Mayo Clinic researchers are focused on developing improved treatment for reducing intraocular pressure, while also ide[...] April 02, 2025 Research and new technology aid in improving IOL prediction accuracy, patient outcomes There is a constant call for improvement in IOL power calculation accuracy. To achieve this in an increased number of patients – while also improving accuracy in patients with less common eye measurements – researchers [...] April 02, 2025 Residents highlight camaraderie, robust educational foundation Mayo Clinic's Ophthalmology Residency draws trainees from diverse backgrounds, family status, and professional and personal interests. Learn more about some Mayo Clinic residents' experiences so far. Jan. 17, 2025 Catch up on our top 10 podcasts of 2024 Discover the top 10 most-popular 2024 Mayo Clinic Ophthalmology Podcasts, hosted by Erick D. Bothun, M.D., and Andrea A. Tooley, M.D. Nov. 23, 2024 First FDA-approved retinal gene therapy available at Mayo Clinic The first prescription retinal gene therapy product is now available at Mayo Clinic. For eligible patients, voretigene neparvovec-rzyl is a one-time gene therapy that has the potential to restore the visual cycle and to[...] Nov. 23, 2024 Pediatric myopia clinic prioritizes early intervention and research Early intervention and detection in children with myopia is the key to reducing the long-term impact on patients' ocular health. Mayo Clinic's pediatric myopia clinic offers coordinated care within a multidisciplinary t[...] Nov. 23, 2024 Valuable addition to the team brings shared dedication to patients, passion for research and education Greg J. Griepentrog, M.D., has joined Ophthalmology at Mayo Clinic in Rochester, Minnesota, bringing his own unique experience and knowledge. Oct. 30, 2024 Global track for residents: International education, bidirectional impact Mayo Clinic introduced a new global ophthalmology and health equities track that thoughtfully prepares residents for local and international experiences. Aug. 28, 2024 Transforming healthcare and research with AI-driven tools Through its patient care and research initiatives, Mayo Clinic has been busy building one of the largest repositories of clinical data in the world. One of the AI-driven tools developed within Mayo Clinic Ophthalmology [...] Aug. 14, 2024 3D-printed models aid complex orbital reconstruction When conditions such as cancer, trauma or complications from previous surgery affect the eyes, as well as surrounding facial structures, patients can benefit from a multidisciplinary approach. The Mayo Clinic Oculofacia[...] Aug. 14, 2024 Ophthalmic Pathology at Mayo Clinic Mayo Clinic has had a longtime tradition of expertise and excellence in the field of ophthalmic pathology. Currently, Ophthalmic Pathology includes four subspecialized pathologists who review more than 800 cases every y[...] March 16, 2024 Expanding pediatric cornea, cataract and glaucoma care Dr. Kim will help care for children with complex anterior segment disorders, specifically in the areas of pediatric cornea, cataract and glaucoma. March 16, 2024 Individualizing patient care through research, expertise Ruti Sella Svetlit, M.D., brings her expertise in anterior segment ocular surgery and refractive surgery to help treat patients with cataract and refractive error at Mayo Clinic in Rochester, Minnesota. Jan. 16, 2024 Collaborative surgical innovation can reduce complications and hospital stay Meningiomas account for 15% to 20% of primary brain tumors. Mayo Clinic ophthalmologists collaborating across the clinical practice has allowed a new treatment option to emerge for anterior skull base meningioma resecti[...] Oct. 14, 2023 Textbook review: Evolutionary analysis of pediatric eye movement disorders A scientific textbook by Michael C. Brodsky, M.D., an ophthalmologist at Mayo Clinic in Rochester, Minnesota, provides a comprehensive neurologic explanation for the unique eye movement disorders that afflict children w[...] Oct. 14, 2023 Dry eye clinic offers new testing and treatments Mayo Clinic's new dry eye clinic offers new imaging and treatment options, along with comprehensive, multidisciplinary care. Aug. 04, 2023 Potential one-time gene therapy treatment for wet age-related macular degeneration Dr. Sophie J. Bakri, an ophthalmologist at Mayo Clinic in Rochester, Minnesota, performed the first subretinal gene therapy as part of a clinical study of RGX-314 as a potential one-time gene therapy for wet AMD. April 27, 2023 Pediatric retina surgery program ensures patient-centered care Dr. Brittni A. Scruggs, an ophthalmologist at Mayo Clinic in Rochester, Minnesota, leads the effort to use the latest technology and research to provide comprehensive pediatric retina care. April 27, 2023 Thyroid Eye Disease Clinic offers customized, collaborative approach to treatment Mayo Clinic's Thyroid Eye Disease Clinic offers a collaborative approach that helps streamline diagnostic processes and treatment recommendations. Oct. 01, 2022 Mayo Clinic Ophthalmology Podcast Hosted by Erick D. Bothun, M.D., and Andrea A. Tooley, M.D., the Mayo Clinic Ophthalmology Podcast features guests from around the world to discuss ophthalmology and various subsets of medicine. Oct. 01, 2022 New study assesses the risk of stroke before and after central retinal artery occlusion Mayo Clinic researchers analyzed population-based data to study the correlation between central retinal artery occlusion and incidence of ischemic stroke to evaluate the associated risk. Oct. 01, 2022 Welcoming new ophthalmologist to Mayo Clinic Board-certified ophthalmologist Ashlie A. Bernhisel, M.D., has joined Ophthalmology at Mayo Clinic in Rochester, Minnesota. July 27, 2022 Reexamining the relationship among metabolic syndrome, CCT and ocular hypertension Mayo Clinic study shows that metabolic syndrome is associated with ocular hypertension. The results also suggest that this association may be related to increased central corneal thickness. July 27, 2022 Drusen phenotypes associated with advanced age-related macular degeneration Reticular pseudodrusen, basal laminar drusen and calcified drusen all showed a strong association with more-advanced stages of age-related macular degeneration, according to a Mayo Clinic study. The study also showed a [...] July 27, 2022 Children diagnosed with type 2 diabetes, increased risk of developing vision-threatening retinopathy A retrospective study shows that children diagnosed with type 2 diabetes developed retinopathy after a shorter diabetes duration and at a higher rate than children with type 1 diabetes. March 12, 2022 Optic effect on peripheral retinal illumination holds implications for negative dysphotopsia Mayo Clinic researchers used ray-tracing analysis to compare the influence of 6.0 mm and 7.0 mm intraocular lens optic diameters on illumination of the peripheral retina. March 12, 2022 Many ophthalmic irAEs can be treated without discontinuation of life-prolonging immunotherapy Ophthalmic immune-related adverse events (irAEs) associated with using immune checkpoint inhibitors (ICIs) are rare, but ophthalmologists need to recognize irAEs and un[...] March 12, 2022 Mobile platform obtains quantitative measurements of exophthalmos with variability similar to Hertel exophthalmometry A simple-to-use mobile application yields reliable, accurate measurements in a timely, efficient manner — and may be a suitable alternative when Hertel exophthalmometry is not available for measurement of globe po[...] Jan. 07, 2022 Data and communication support individualized pediatric retinoblastoma program Evidence-based practices and communication with families are key to pediatric retinoblastoma care. Mayo Clinic physicians work collaboratively with one another, the patient's family and global data to advance retinoblas[...] July 20, 2021 Study supports the use of plaque imaging in the evaluation of patients with acute retinal artery occlusion Researchers found that patients with retinal artery occlusion (RAO) had higher prevalence of intraplaque hemorrhage (IPH). The presence of IPH was independently associated with ipsilateral RAO. April 20, 2021 Standardized prescribing guidelines reduce frequency and quantity of opioids prescribed Development of standardized opioid prescribing guidelines and discussion of postsurgical pain management reduced the overprescribing of opioids without increasing refill rates. April 20, 2021 Studies support Scheimpflug tomography's efficacy in predicting the prognosis of FECD Studies confirm that the presence of even one or two map features increased the probability of Fuchs' endothelial corneal dystrophy (FECD) progression independent of central corneal thickness. March 20, 2021 Retinoblastoma: Specialized neuroradiology for optimal care Mayo Clinic's experienced specialists work to preserve the child's life, eye and sight. March 11, 2021 Regenerative approaches to improving corneal transplantation Mayo Clinic offers two partial-thickness corneal transplants for patients with diseased endothelial cells. Advancements in transplantation surgery make it possible to improve eyesight without removing the full thickness[...] Sept. 14, 2019 Study finds most conjunctival tumors benign with low risk of malignant transformation While most conjunctival tumors are benign with low risk of malignant transformation, researchers recommend subspecialty referrals in the setting of changing appearance or worrisome features. Sept. 14, 2019 Study supports increased risk of ischemic stroke in the peri-CRAO period Research supports that there is an increased risk of stroke around the time of central retinal artery occlusion (CRAO), especially if an embolic etiology of CRAO is diagnosed. Sept. 14, 2019 Use of intraocular lenses relatively safe for treatment of cataracts in infants ages 7 to 24 months old The Toddler Aphakia and Pseudophakia Study (TAPS) evaluated concerns about adverse events, re-operations and refractive changes in infants who receive intraocular lens implantation for cataract. July 16, 2019 Study identifies clinical phenotype, visual outcomes of MOG-IgG antibody optic neuritis Research supports that MOG-IgG positivity should be suspected if optic disk edema is moderate to severe at onset or if MRI shows optic nerve sheath involvement. Feb. 01, 2019 Patients with central retinal artery occlusion require embolic work-ups Research published in Mayo Clinic Proceedings indicates symptomatic stroke, TIA or amaurosis fugax is common around the time of central retinal artery occlusion. Researchers recommend urgent embolic work-ups for those p[...] Sept. 21, 2018 Surgical treatment impacts health-related quality of life for patients with glaucoma Patients with glaucoma report poor health-related quality of life due to worse diplopia, lower mean deviation on visual field testing in either eye, decreased visual acuity in either eye, younger age, and previous glauc[...] April 15, 2017 The causes of acquired 3rd nerve palsy A study using Rochester Epidemiology Project (REP) records demonstrates a higher incidence of microvascular and a lower incidence of aneurysmal third nerve palsies than previously reported in nonpopulation-based studies[...] Nov. 01, 2016 Eye in the Storm A clinician and investigators with Ophthalmology at Mayo Clinic in Rochester, Minnesota, team to learn how toxic RNA short-circuits corneal cells. 医疗专业人员 Ophthalmology news